drugset

drugset / Trial / NCT00257595

Perennial Allergic Rhinitis In Pediatric Subjects

NCT00257595 ↗

Phase 3 Completed 30 enrolled GlaxoSmithKline

RandomizedSingle-groupOpen-labelTreatment

Summary

To assess the safety of long-term use of cetirizine dry syrup in children with perennial allergic rhinitis.

Timeline

Start: 2005-08
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cetirizine	Other / unclassified	—	—

Indications